Role of Surfactant Protein-A in Nitric Oxide Production and Mycoplasma Killing in Congenic C57BL/6 Mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 3, 2004, Pages 319-325

  Hickman Davis, Judy M ^a   Gibbs Erwin, Julie ^a   Lindsey, J Russell ^a   Matalon, Sadis ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROTEIN; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; LUNG LAVAGE; LUNG LOBE; MYCOPLASMA; NONHUMAN; PATHOGENESIS; STIMULUS RESPONSE;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CELLS, CULTURED; CYTOKINES; GENOTYPE; LUNG; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOPLASMA INFECTIONS; MYCOPLASMA PULMONIS; NITRATES; NITRIC OXIDE; NITRITES; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA PULMONIS; MYCOPLASMATALES;

EID: 1542374725     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0246OC     Document Type: Article

References (31)

1. Howard, C. J., and G. Taylor. 1983. Interaction of mycoplasmas and phagocytes. Yale J. Biol. Med. 56:643-648.
2. Webster, A. D., P. M. Furr, N. C. Hughes-Jones, B. D. Gorick, and D. Taylor-Robinson. 1988. Critical dependence on antibody for defence against mycoplasmas. Clin. Exp. Immunol. 71:383-387.
3. Hickman-Davis, J. M., J. R. Lindsey, and S. Matalon. 2001. Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis. Infect. Immun. 69:6401-6410.
4. Hickman-Davis, J. M., S. M. Michalek, J. Gibbs-Erwin, and J. R. Lindsey. 1997. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect. Immun. 65:2278-2282.
5. Hickman-Davis, J. M., J. R. Lindsey, S. Zhu, and S. Matalon. 1998. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am. J. Physiol. 274:L270-L277.
6. Hickman-Davis, J., J. Gibbs-Erwin, J. R. Lindsey, and S. Matalon. 1999. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc. Natl. Acad. Sci. USA 96:4953-4958.
7. Hickman-Davis, J. M. 2001. Implications of mouse genotype for phenotype. News Physiol. Sci. 16:19-22.
8. Hickman-Davis, J. M., P. O'Reilly, I. C. Davis, J. Peti-Peterdi, G. Davis, K. R. Young, R. B. Devlin, and S. Matalon. 2002. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L944-L956.
9. Korfhagen, T. R., M. D. Bruno, G. F. Ross, K. M. Huelsman, M. Ikegami, A. H. Jobe, S. E. Wert, B. R. Stripp, R. E. Morris, S. W. Glasser, C. J. Bachurski, H. S. Iwamoto, and J. A. Whitsett. 1996. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93:9594-9599.
10. Misko, T. P., R. J. Schilling, D. Salvemini, W. M. Moore, and M. G. Currie. 1993. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:11-16.
11. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. 1996. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64:5326-5331.
12. Murray, A. B., and A. Luz. 1990. Acidophilic macrophage pneumonia in laboratory mice. Vet. Pathol. 27:274-281.
13. Guo, L., R. S. Johnson, and J. C. Schuh. 2000. Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice. J. Biol. Chem. 275:8032-8037.
14. LeVine, A. M., K. E. Kurak, M. D. Bruno, J. M. Stark, J. A. Whitsett, and T. R. Korfhagen. 1998. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 19:700-708.
15. LeVine, A. M., J. Gwozdz, J. Stark, M. Bruno, J. Whitsett, and T. Korfhagen. 1999. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 103:1015-1021.
16. LeVine, A. M., K. Hartshorn, J. Elliott, J. Whitsett, and T. Korfhagen. 2002. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L563-L572.
17. LeVine, A. M., K. E. Kurak, J. R. Wright, W. T. Watford, M. D. Bruno, G. F. Ross, J. A. Whitsett, and T. R. Korfhagen. 1999. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am. J. Respir. Cell Mol. Biol. 20:279-286.
18. LeVine, A. M., J. A. Whitsett, J. A. Gwozdz, T. R. Richardson, J. H. Fisher, M. S. Burhans, and T. R. Korfhagen. 2000. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 165:3934-3940.
19. Linke, M. J., C. E. Harris, T. R. Korfhagen, F. X. McCormack, A. D. Ashbaugh, P. Steele, J. A. Whitsett, and P. D. Walzer. 2001. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J. Infect. Dis. 183:943-952.
20. Li, G., J. Siddiqui, M. Hendry, J. Akiyama, J. Edmondson, C. Brown, L. Allen, S. Levitt, F. Poulain, and S. Hawgood. 2002. Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. Am. J. Respir. Cell Mol. Biol. 26:277-282.
21. Green, E. U. 1942. On the occurrence of crystalline material in the lungs of normal and cancerous Swiss mice. Cancer Res. 2:210-217.
22. Ward, J. M. 1978. Pulmonary pathology of the motheaten mouse. Vet. Pathol. 15:170-178.
23. Cartner, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138-4142.
24. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. 1996. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64:5326-5331.
25. Davidson, M. K., J. R. Lindsey, R. F. Parker, J. G. Tully, and G. H. Cassell. 1988. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect. Immun. 56:2156-2162.
26. Blau, H., S. Riklis, J. F. Van Iwaarden, F. X. McCormack, and M. Kalina. 1997. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am. J. Physiol. 272:L1198-L1204.
27. Harrod, K. S., B. C. Trapnell, K. Otake, T. R. Korfhagen, and J. A. Whitsett. 1999. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am. J. Physiol. 277:L580-L588.
28. Sano, H., H. Sohma, T. Muta, S. Nomura, D. R. Voelker, and Y. Kuroki. 1999. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 163:387-395.
29. Murakami, S., D. Iwaki, H. Mitsuzawa, H. Sano, H. Takahashi, D. R. Voelker, T. Akino, and Y. Kuroki. 2002. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J. Biol. Chem. 277:6830-6837.
30. Rosseau, S., P. Hammerl, U. Maus, A. Gunther, W. Seeger, F. Grimminger, and J. Lohmeyer. 1999. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes. J. Immunol. 163:4495-4502.
31. Hussain, S., J. R. Wright, and W. J. Martin. 2003. Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factor-alpha-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 28:520-527.